A Study to Validate the Safety and Feasibility of ArtiSential in Colorectal Cancer Surgery Using Prospectively Constructed Multi-center Registry

Recruiting now

Conditions studied: Rectal Cancer, Rectosigmoid Cancer, Rectosigmoid Junction Cancer

In brief

This study is to validate the safety and feasibility of ArtiSential (Articulating laparoscopic instrument) colorectal surgery and compare it with robotic surgery for patients with rectal cancer and rectosigmoid junction cancer.

Key facts

Study ID

NCT05566249

Run by

Samsung Medical Center

People needed

1000

Starts

2022-10-01

Expected to finish

2029-12-31

Last updated by the study team

2022-10-06

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age : 18 \~ 80 year old male or female
• Biopsy-proven adenocarcinoma
• Rectal cancer or Rectosigmoid junction cancer
• Primary cancer
• Non-metastatic cancer
• Planned (or elective) curative resection
• Low anterior resection with double-stapled technique

You may not qualify if…

• Preoperative systemic chemotherapy
• Distant metastasis at initial diagnosis
• Palliative surgery
• Emergent surgery
• Lynch syndrome or FAP-associated cancer

Where it is running

• Samsung Medical Center — Seoul, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.